Status:
COMPLETED
Alleviating Effects Against High Intraocular Pressure by Oral Intake of Cordyceps Cicadae Mycelia
Lead Sponsor:
Han-Hsin Chang
Collaborating Sponsors:
Grape King Bio Ltd.
Conditions:
Supplement
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
This study will investigate the effects of lowering intraocular pressure by oral intake of Cordyceps cicadae mycelia, to provide evidence-based data for high intraocular pressure relief.
Detailed Description
Study purpose This study investigated the effeicacy of oral Cordyceps cicadae mycelia for the relief of high intraocular pressure. Subjects 1. The total recruitment of subjects is 60 people, aged be...
Eligibility Criteria
Inclusion
- Age between 20 and 75 years old, regardless of gender.
- Pre-test confirmation of high intraocular pressure.
- Subjects should understand the trial and agree to join the project.
Exclusion
- Age under 20 or over 75 years.
- Use intraocular pressure lowering drugs other than Taflotan (saflutan).
- Using beta-blockers or diuretics.
- Being pregnant.
- Disabled individuals with specific diseases or malfunction, for example tumours at terminal stage, blindness.
- Loss of self-consciousness and behavioral capacity.
- Patients with major diseases.
- Withdrawal criteria All subjects may withdraw at any time without any reason. The act of withdraw does not affect rights for them to seek medical advice or treatments.
Key Trial Info
Start Date :
March 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05304299
Start Date
March 10 2020
End Date
December 31 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Han-Hsin Chang
Taichung, Taiwan